Discovery & Development US 2026
.png)
October 2026
San Diego, CA
San Diego, CA
"One of the best parts of Discovery & Development US 2025 has been the spontaneous conversations with people I hadn’t planned to meet. Even when the topics were outside my usual focus, I found myself fascinated by the work others are doing. It’s a great reminder of how broad and inspiring this industry is."
Andrew Geall
Co-Founder and Chief Development Officer,
Replicate Bioscience Inc
Beth Hoffman
President & Chief Executive Officer,
Origami Therapeutics, Inc.
Bindhu Rayaprolu
Director,
Regeneron
Craig Behnke
Executive Vice President, Production and Development,
Lumen Bioscience Inc
David Buckler
Executive Director - Research Program Management,
Regeneron Pharmaceuticals
Dimitrios Zisoulis
Head of RNA Therapeutics,
Johnson & Johnson Innovative Medicine
Maria Sörhede Winzell
Senior Director,
Camurus
Peggy Thompson
Vice President, Head of Biology,
Plexium
Prashi Jain
Director, Drug Discovery,
Iterion Therapeutics
Raymond Deshaies
Senior Vice President,
California Institute of Technology
Steve Turner
Chief Executive Officer,
Pacific Biosciences
Abhinav Sharma
Translational Human Models Lead,
AbbVie
Anisha D'Souza
Research Scientist,
Northeastern University
Ashley Davalos
Assistant Director,
Ionis Pharmaceuticals
Catherine Cahill
Assistant Professor,
Harvard University
David Loynd
CEO,
EnduRx Pharmaceuticals Inc
Elena Liang
Principal Research Scientist,
AbbVie
Enrico Zambelli
Principal Formulation Scientist,
Chiesi
Eric Munson
Professor,
Purdue University
Fabien Vincent
Research Fellow Laboratory Head Primary Pharmacology Group (PPG)Discovery Sciences,
Pfizer Ltd
Jack Rogers
Director,
Neurochemistry at Harvard University
Jamie Tsung
Director,
Alnylam Pharmaceuticals
Jean Ge
Patent Attorney,
Wolf Greenfield
Jianqin Lu
Associate Professor,,
University of Arizona
Jitendra Kumar
Lead Scientist - Chemistry & Process Development,
Entos Pharmaceuticals Inc
Joseph Wu
Director, Stanford Cardiovascular Institute,
Stanford University
Josh Baughman
Scientific Director,
Bristol Myers Squibb
Kalpita Mehta
Principal Combination Production & Medical Device Expert,
Hikma
Katherin Patsch
Director, Drug Discovery,
Ellison Medical Institute
Kausheek Nandy
Digital Transformation Director - Research,
Boehringer Ingelheim
Lan Fong
Founder,
Avery Biopharma Consulting & Avery Capital Group
Lei Jia
Associate Director, Drug Discovery Data Science,
Johnson & Johnson
Mark Eccleston
Chief Executive Officer,
ValiRx
Maya Gosztyla
Chief Scientific Officer,
BrainStorm Therapeutics
Peter Heifetz
Chief Executive Officer,
Orpro Therapeutics
Phil Cox
Research Fellow, Discovery Research,
AbbVie
Ramesh Kashi
Former Senior Scientific Director,
Bristol Myers Squibb
Rick Ewing
Vice President, Head of Chemistry,
Rapafusyn
.jpg?length=600&name=0fb1b4ab-4ed2-48a6-9be5-636a65a005fd-2-11764368speaker_photo-IMG_8722-(3).jpg)
Robert Fremeau
Founder and Chief Executive Officer,
BrainStorm Therapeutics, Inc.
Sam Sinai
Vice President, Head of Machine Learning,
Dyno Therapeutics
Sayoni Ray
Principal Scientist,
Johnson & Johnson
Sean Sullivan
Vice President,
Arcturus Therapeutics, Inc.
Severin Schneebeli
Associate Professor,
Purdue University
Shanthi Nagarajan
Director,
Eli Lilly
Shilpa Thosar
Founder and Principle Consultant,
VSanTech Pharmaceutical Consulting
Shuangwei Li
Director of Toxicology,
Calibr-Skaggs Institute for Innovative Medicines
Stefano Zanotti
Senior Vice President, Head of Neuromuscular Research,
Dyne Therapeutics
Stephen Framil
Corporate Global Head of Accessibility,
Merck & Co., Inc.
Sunita Yadav
Associate Director,
Novartis Pharma
Surendra Nayak
Scientific Assoc Director,
BMS
Tobias Raabe
Director, Translational Genome Editing Laboratory, Perelman School of Medicine,
University of Pennsylvania
Vivek Gupta
Associate Dean,
St. John's University
Yue Webster
Vice President,
Eli Lilly
Meet Our Esteemed Sponsors
Platinum Sponsors
10x Genomics
Platinum Sponsor
10x Genomics was founded on the vision that this century will bring advances in biomedicine and transform the way we understand and treat disease. We deliver powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Our end-to-end single cell and spatial solutions include instruments, consumables, and intuitive software, letting you unravel highly intricate biological systems, while bringing into focus the details that matter most.
Bruker Spatial Biology
Platinum Sponsor
Bruker Spatial Biology, a division of Bruker Corporation, provides advanced spatial molecular biology solutions, including instruments, assays, software, and services to support life sciences research. By integrating technologies from NanoString and Canopy Biosciences, Bruker offers an extensive portfolio designed to meet the diverse needs of global researchers exploring spatial biology.
The CosMx® Spatial Molecular Imager (SMI) enables high-plex detection and analysis of over 6,000 RNAs with single-cell resolution and precise cell segmentation, supported by the cloud-based AtoMx™ Spatial Informatics Platform. The GeoMx® Digital Spatial Profiler is a leading platform for whole-tissue exploration, providing whole transcriptomics and high-plex proteomic readouts. The CellScape™ Precise Spatial Proteomics platform allows for high-plex protein expression analysis at single-cell resolution, using versatile, open-sourced reagents. The nCounter® Analysis System enables rapid quantification of profiling of gene and miRNA expression with high sensitivity.
Together, Bruker Spatial Biology’s solutions are supported by a strong team of scientists, sales, and service associates, along with Canopy Multiomic Services for biopharmaceutical research, assay development, and clinical sample testing.
For more information, visit www.BrukerSpatialBiology.com.
Gold Sponsors
ariadne.ai
Gold Sponsor
ariadne.ai ag is your partner for biomedical image analysis. Our cloud-based, worry-free SPATIAL platform enables the analysis of multiplexed spatial proteomics, transcriptomics and multi-omics data, including precise stitching, registration, segmentation and statistical analyses of cellular neighborhoods. SPATIAL works with any data type, whether you have fluorescence or histopathological staining, 2d or 3d data, or complex cell types such as neurons. Our experienced team of annotators and software engineers will design and implement custom solutions to any image analysis challenge, no matter the tissue, device or assay.
Cell Signaling Technology
Gold Sponsor
CST® is a privately-owned, global company headquartered in Danvers, Mass., USA. Founded in 1999 and still led by research scientists. We are actively engaged in the development of products and technologies that facilitate signaling analysis and mechanistic cell biology and cancer research.
Miltenyi Biotec, Ltd.
Gold Sponsor
For over 30 years, Miltenyi Biotec has been a leader in the development of products that empower the advancement of biomedical research and enable cell and gene therapy. We provide innovative tools to help with your sample preparation, cell isolation, cell culture, and cell analysis needs. Our solutions are designed to support everything from basic research to translational research and clinical application for immunology, stem cell biology, neuroscience, and cancer.
Quantum-Si
Gold Sponsor
Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company’s Platinum® Pro benchtop instrument enables Next-Generation Protein Sequencing™ that advances proteomic research, drug discovery, and diagnostics beyond what has been possible with existing proteomic tools. Detecting single amino acids through binding kinetics, the innovative Platinum® Pro benchtop sequencer is highly sensitive to protein variants, enabling deep interrogation of proteins to deliver breakthrough insights.
Singular Genomics
Gold Sponsor
Our recently launched G4X Spatial Sequencer, which is an upgrade to the G4 Sequencing Platform, is designed to offer high throughput in situ direct sequencing of RNA (Direct-Seq™), targeted transcriptomics, and proteomics profiling from formalin-fixed, paraffin-embedded (FFPE) tissues
Vizgen
Gold Sponsor
Vizgen is at the forefront of spatial biology and multi-omics innovation. Through its pioneering MERFISH technology and MERSCOPE® Platform for in situ single-cell spatial genomics and its high-fidelity InSituPlex® protein assays and AI-driven STARVUE™ spatial image analysis technology, Vizgen delivers unmatched tools that enable researchers to uncover deep insights into human biology and achieve breakthroughs in understanding mechanisms of complex diseases. Vizgen’s technology delivers high-confidence, quantitative data with exceptional accuracy, robustness, sensitivity and deep insights that power foundational and clinical research. Vizgen is headquartered in Cambridge, Massachusetts, and can be found online at www.vizgen.com and www.ultivue.com. Connect on social media Twitter, LinkedIn and Facebook.
Silver Sponsors
ACD, Bio-Techne
Silver Sponsor
ACD - a Bio-Techne brand, is a pioneer and leader in the advancement of spatial genomics and clinical applications by unlocking the power of RNA and developing cell- and tissue-based research and diagnostic tests for personalized medicine.
Based in Silicon Valley, ACD’s proprietary RNAscope™ technology, the first multiplex fluorescent and chromogenic in situ hybridization platform, enables detection and quantification of single RNA molecules in situ. Our portfolio includes, RNAscope, BaseScope™, miRNAscope™ and HiPlex™ v2. With over 50,000 probes and our Professional Assay Services, we enable rapid assessment of unique targets. Since launch in 2011, the technology boasts 10,000+ citations, with new peer reviewed publications daily.
Based on proprietary technology, ACD’s RNAscope Technology, the first multiplex fluorescent and chromogenic in situ hybridization platform enables detection and quantification of RNA in situ at single molecule sensitivity.
Ardigen S.A.
Silver Sponsor
Ardigen is a leading AI Contract Research Organisation (CRO) dedicated to increasing the success rate of drug discovery. Recognized among the top 5% of AI in drug discovery companies worldwide, Ardigen integrates expertise in biology, bioinformatics, machine learning, and software engineering to deliver advanced computational solutions exclusively tailored for the biotechnology and pharmaceutical sectors. Over the past 10 years, we have earned the trust of over 120 clients, including 15 major pharmaceutical companies, by providing exceptional in silico research and data engineering services.
Complete Genomics
Silver Sponsor
Complete Genomics is a pioneering life sciences company offering innovative, comprehensive sequencing solutions, including sample/library preparation, lab automation, sequencing, and data analysis. Our sequencing portfolio features a full range of sequencers designed to meet low, medium, and high throughput needs, all powered by our proprietary DNBSEQ technology. To date, over 9,700 publications have utilized DNBSEQ technology across a broad spectrum of applications.
As the exclusive distributor of STOmics products in North America, Complete Genomics provides access to Stereo-seq technology—the only spatial transcriptomics solution worldwide capable of exploring the entire transcriptome at true single-cell resolution.
To learn more, visit https://www.completegenomics.com
GENEWIZ from Azenta Life Sciences
Silver Sponsor
As a global leader in R&D genomics services, GENEWIZ from Azenta Life Sciences, leads the way in providing superior data quality with unparalleled technical support to enable researchers around the world to advance their scientific discoveries faster than ever before.
Our customers at top-tier pharmaceutical, biotechnology, and academic institutions, as well as cutting-edge start-ups, rely on our proprietary technologies for consistent, reliable, high-quality data, even on the most difficult projects. A full-service provider, we provides Sanger DNA sequencing, gene synthesis, molecular biology, high throughput/next generation sequencing, bioinformatics, and GLP regulatory services.
Hamilton
Silver Sponsor
Hamilton Company specializes in the development, manufacturing and customization of precision measurement devices, automated liquid handling workstations, and sample management systems. Hamilton's processes are optimized for quality and flexibility. Whether it's a custom needle with a quick delivery time frame, a special length pH sensor, or a comprehensive solution to fully automate your assay workflow, trust that Hamilton products will always meet your needs.
Hamilton Company has been a leading global manufacturer for more than 60 years, with headquarters in Reno, Nevada;Franklin, Massachusetts;Timișoara, Romania;Bonaduz, Switzerland;and subsidiary offices throughout the world.
Lunaphore Technologies SA, a Bio-Techne company
Silver Sponsor
Lunaphore Technologies S.A. – a Bio-Techne brand, is a Swiss company born in 2014 with the vision of enabling spatial biology in every laboratory. Lunaphore provides solutions based on a game-changing chip technology that can extract spatial proteomic and transcriptomic data from tumors and other tissues, transforming any assay into multiplex spatial biology through a streamlined and easily integrated process. Lunaphore empowers researchers in immunology, immuno-oncology, and neuroscience to push the boundaries of scientific discovery and drug development. Lunaphore’s technology enables the identification of biomarker “signatures” with clinical relevance to support the development of diagnostic tools and streamline clinical trials, to ultimately improve patient outcomes. For further information on Lunaphore and its products, please visit https://lunaphore.com.
Navinci
Silver Sponsor
Navinci is a Swedish biotech company specializing in developing innovative solutions for studying protein interactions. With a focus and a strong legacy in developing in situ proximity ligation assay technology, Navinci has established itself as a center of excellence in the field and has a broad portfolio of products that help researchers study protein interactions in depth.
NeoGenomics Laboratories
Silver Sponsor
NeoGenomics is a premier cancer diagnostics company, specializing in cancer genetics testing and information services. We offer one of the most comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with innovative diagnostic and predictive testing to help them diagnose and treat cancer. We partner with pharmaceutical clients from discovery to commercialization with broad oncology testing capabilities powered by in-house scientific expertise and dedicated project support teams. Our clients benefit from our state-of-the-art molecular technology, from whole exome sequencing, whole transcriptome sequencing, HLA typing, and the proprietary MultiOmyx™ high-order multiplexing methodology.
Olink
Silver Sponsor
Olink offers an unmatched high-multiplex technique to identify actionable biomarkers, with a strong focus on the human plasma proteome. Using minimal sample volume we provide quantifiable results with high-throughput, exceptional sensitivity and specificity, with coverage across a broad dynamic range. Our mission is to accelerate proteomics together with the scientific community across multiple disease areas to enable new discoveries and better understand complex real-time human biology. We are committed to develop our offering and are continuously expanding our protein coverage for a growing number of biological processes and pathways.
Olink is well-established in Europe (HQ Uppsala, Sweden) and the USA (HQ Boston, MA), with a rapidly developing presence across Asia. We also work with a growing number of core labs around the world offering analysis and support to an expanding global customer base.
Parse Biosciences
Silver Sponsor
Parse Biosciences is a Seattle-based company with the mission of accelerating progress in human health and scientific research. At the core of our company is our pioneering approach for single cell sequencing. Single cell sequencing has already enabled groundbreaking discoveries which have led to new understandings of cancer treatment, tissue repair, stem cell therapy, kidney and liver disease, brain development, and the immune system.
Sapient Bioanalytics
Silver Sponsor
Sapient is a leader in multi-omics discovery, providing bespoke services for proteomics, metabolomics, lipidomics data generation and delivering insights that enable biopharma sponsors to go beyond the genome to accelerate precision drug development.
Utilizing cutting-edge, high throughput mass spectrometry, we make nontargeted and targeted measurements to capture thousands of dynamic biomarkers – including proteins, metabolites, and lipids – per sample, across thousands of samples at a time. We pair this with advanced biocomputational frameworks enabling comprehensive biomarker-phenotype mapping and integrative analyses with other omics and real-world data.
Aided by our proprietary Human Biology Database — comprising data from tens of thousands of samples in which we can mine for and validate biomarkers and targets — we can support rapid drug target identification, biomarker discovery and validation, and translational insights across all stages of drug development, including clinical trials.
Scale Biosciences
Silver Sponsor
Scale Biosciences is at the forefront of a new era in single cell research, providing scientists with the tools they need to push the boundaries of biological discovery. Our innovative platforms combine accessibility, flexibility, and scalability, allowing researchers to design experiments that fit their unique scientific objectives without compromising on quality or results. By enabling the analysis of up to millions of cells and the multiplexing of hundreds of samples, Scale Bio empowers scientists to generate rich, comprehensive datasets that can unlock new insights into complex biological systems. We are dedicated to collaborating with the scientific community to drive innovation and accelerate breakthroughs in single cell-omics. Join Scale Bio on this transformative journey and help unleash the full potential of single cell research today.
Single Cell Discoveries
Silver Sponsor
Single Cell Discoveries is a Contract Research Organization (CRO) specializing in innovative single-cell sequencing technologies, multi-omic applications, and spatial transcriptomics. Single Cell Discoveries delivers high-impact insights to biopharmaceutical companies, healthcare systems, and academic research centers worldwide. Single Cell Discoveries' mission is to accelerate groundbreaking research by developing and providing state-of-the-art single-cell technologies as a service.
.jpg?length=600&name=a396bca6-7435-42de-8524-0ee4844b758e-2-5668375logo-standardbio-color-logo-blue-outline-blue-TM-(2).jpg){kind=logo}
Standard BioTools
Silver Sponsor
Standard BioTools™, previously known as Fluidigm®, is driven by a bold vision – Unleashing tools to accelerate breakthroughs in human health. Standard BioTools provides an established portfolio of essential, standardized technologies that empower customers to scale and accelerate their life sciences research. From interrogating cell function and cancer-immune cell interactions to confidently determining new biomarkers or integrity of samples, Standard BioTools promotes the development of breakthrough medicines faster and better through the delivery of consistent, reliable and repeatable results.
Bronze Sponsors
Aspect Analytics
Bronze Sponsor
Aspect Analytics develops enterprise software to analyze and integrate spatial omics data. Spatial technologies are steadily maturing into a key enabler in drug development, biomarker discovery, and life science research. With spatial omics datasets commonly generating tens to hundreds of gigabytes of complex data in a single experiment, data analysis is becoming a critical bottleneck in the adoption of this emerging technology. Aspect Analytics bridges the gap between algorithmic development in bioinformatics research and enterprise-grade software platforms to support key spatial omics-based applications. Our software can (i) extract maximal knowledge from spatial data, including co-registration with different modalities, (ii) scale up for high-throughput applications and (iii) provide integrated data management, traceability and more. Aspect Analytics enables breakthrough research and facilitates cross-disciplinary teamwork by bringing spatial multi-omics data into a single view, collaborative platform.
Atrandi Biosciences
Bronze Sponsor
Atrandi Biosciences is a pioneering life sciences tool company transforming single-cell analysis with Semi-Permeable Capsule (SPC) technology. SPCs redefine how single-cell research is done, enabling multi-step, high-throughput workflows while maintaining true single-cell resolution. Unlike conventional methods, SPCs allow researchers to perform multiomic assays seamlessly, unlocking deeper insights into biology. Founded by leading scientists and driven by a mission to simplify research and advance discovery, Atrandi is shaping the future of single-cell analysis and empowering scientists worldwide.
Beckman Coulter
Bronze Sponsor
We are a life sciences company that provides an extensive portfolio of solutions for workflow innovation, lab automation of routine tasks/complex methods, and software solutions to advance your research.
Our lab automation solutions and genomic reagents portfolio facilitate seamless processes for DNA/RNA clean-up, size selection, extraction, and sample preparation for NGS, RNA-seq, and single-cell transcriptomics. By integrating our advanced solutions into your lab, you can achieve high-quality, reproducible data, empowering your AI and machine learning models.
Becton Dickinson Biosciences
Bronze Sponsor
BD is a leading medical technology company that benefits countless lives worldwide. We advance health by improving the ways that discovery, diagnostics and delivery of care are conducted. With 45,000 employees at work in more than 50 countries, we work in close collaboration with customers and partners to develop innovative products and solutions that enhance outcomes, better manage healthcare delivery costs, increase efficiencies, improve healthcare safety, and expand access to health. Because we’ve been doing this for over 100 years, our portfolio, leadership and partnerships make a difference for global healthcare. For more information, please visit: www.bdbiosciences.com
CS Genetics
Bronze Sponsor
CS Genetics delivers simplicity in a world of complex, time-consuming and expensive single cell genomics workflows. Our nimble, experienced team understands that tomorrow’s discoveries require technology that is simple to adopt and easy to use with near-limitless scalability.
Our transformative new technology for single cell genomics replaces complex hardware and manual time-consuming workflows with a simple, instrument-free, solution-based, Kinetic Confinement assay that plugs seamlessly into any molecular biology laboratory. This simplicity also enables an affordable price point so researchers will no longer have to limit the scale of their studies.
.png?length=600&name=23c79081-69ce-4042-a188-0a0e10023652-2-5668375logo-Hawk-(RGB-Full-Colour).png)
Hawk Biosystems
Bronze Sponsor
HAWK Biosystems is an innovative biotechnology company based in Bilbao, Spain, and a spin-off from prestigious institutions such as Cancer Research UK (CRUK) and the Francis Crick Institute in London. Founded in 2018 by an exceptional team of scientists and business leaders, HAWK has rapidly positioned itself at the forefront of spatial biology, providing ground-breaking solutions for the analysis of protein functions in tissue.
At HAWK Biosystems, our mission is to develop advanced diagnostic systems that accelerate the progress of personalized medicine, focusing on critical diseases such as cancer. Our cutting-edge technology, QF-Pro®, is a revolutionary platform that enables precise, quantitative analysis of protein functions at a sub-pixel resolution. Unlike traditional techniques, QF-Pro® is capable of identifying protein-protein interactions and post-translational modifications within tissue samples at a resolution of less than 10 nanometers. This innovation provides clinicians and researchers with reproducible, robust, and unbiased data, which has demonstrated significant clinical value. For instance, QF-Pro® has been validated in a study to predict patient response to PD-1/PD-L1 inhibitors in lung cancer, demonstrating its potential to significantly improve treatment outcomes by potentially tripling response rates and doubling survival rates.
Leica Microsystems & Leica Biosystems
Bronze Sponsor
Leica Microsystems develops and manufactures microscopes and scientific instruments for
the analysis of microstructures and nanostructures. Widely recognized for optical precision
and innovative technology, the company is one of the market leaders in compound and stereo
microscopy, digital microscopy, confocal laser scanning and super-resolution microscopy.
Leica Biosystems (LeicaBiosystems.com) is a global leader in cancer diagnostics with the most comprehensive portfolio from biopsy to diagnosis. Our mission of “Advancing Cancer Diagnostics, Improving Lives” is at the heart of our corporate culture. Our easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence.
Levitasbio
Bronze Sponsor
LevitasBio is dedicated to advancing science and
human health by providing researchers with new
and powerful methods for sample preparation and
characterization. The LeviCell platform is a
first-in-class cell enrichment solution powered
by a proprietary, label-free, and gentle Levitation
Technology. Our unique solution generates
high-quality samples while preserving the cells’
native state, enabling researchers across multiple
scientific disciplines to uncover true biology.
Accelerate Scientific Discovery With the Power of
Levitation Technology
.png?length=600&name=3ebab810-7368-4d37-bc16-77d994699581-2-5668375logo-RareCyte_Logo_PMS7585-CoolGray11-(R).png){kind=logo}
RareCyte
Bronze Sponsor
RareCyte provides Precision Biology™ products and services for discovery, translational research and clinical diagnostics. The Orion™ spatial biology platform enables whole-slide highly multiplexed tissue analysis for multiple samples per day. Comprehensive liquid biopsy offerings enable CTC and other rare cell characterization and single cell retrieval for molecular analysis and CDx development.
.png?length=600&name=Zifo_Master%20Logo_Two%20colour_RGB%20(002).png)
Zifo Technologies
Bronze Sponsor
Zifo is a global specialist scientific and process informatics service provider working across research, development, manufacturing and clinical domains with expertise in over 90 partner technologies and platforms. We serve customers from Pharma/Biotech/CRO, Industrial chemicals and Food & Bev, to Consumer Goods and Oil and Gas. Our “Glocal” approach leverages remote delivery to ensure cost-effective delivery and solutions coupled with dedicated local support to ensure engagement, success and qualit
Network & Programme Sponsors
Aliri Bioanalysis
Network & Programme Sponsor
We provide a range of bioanalysis lab, spatial bioanalysis, and spatial biology solutions that will help you advance your molecule from discovery through clinical development and NDA approval, while being backed by a network of technical experts and seasoned scientists.
.svg){kind=logo}
BioLizard
Network & Programme Sponsor
At BioLizard, we “think data” and “speak biology”, partnering with our clients to transform lives. Our expert team combines deep biological knowledge with cutting-edge AI and bioinformatics to tackle complex data challenges in human and animal health. Through our AI-native Bio|Verse platform, we accelerate biomarker discovery and enable actionable insights for modern drug development. With a global presence, we deliver tailored solutions in data management, bioinformatics, and AI to drive your data-driven strategy to biotech, pharma and diagnostic companies. Let’s shape the future of life sciences together—connect with BioLizard today!
.png?length=600&name=77f962ea-48c4-4469-ac13-19f7332176c0-2-5668375logo-DLS-Logo-FullColor-noTag-(4).png){kind=logo}
Discovery Life Sciences
Network & Programme Sponsor
Discovery Life Sciences is a global leader in biospecimens and specialty lab services, enabling the discovery and development of groundbreaking therapeutics and diagnostics. With a robust portfolio of human biospecimens and cellular starting material, preclinical ADME-tox solutions, and cutting-edge specialty lab services, we provide our partners with the tools, data and expertise they need to succeed. From genomics and proteomics to cell biology and molecular pathology, our comprehensive service offerings support every phase of the scientific journey, from research through clinical trials. For more information, visit www.dls.com.
.png?length=600&name=708bd68b-02d3-4436-8882-e6181f86f6da-2-5668375logo-Horizontal-Logo-(White-Background).png){kind=logo}
Elucidate Biotechnologies
Network & Programme Sponsor
Elucidate Bio provides multi-modal spatial biology services, enabling same-tissue imaging of DNA, RNA, and protein with single-cell spatial resolution. Powered by technology licensed from Sizun Jiang at Harvard Medical School/BIDMC, we specialize in single-slide spatial proteomic, transcriptomic, and genomic data
generation and analysis. With rigorous quality control, we deliver high-quality data, detailed analysis, and actionable insights to advance biomarker discovery, therapeutic development, and precision medicine. Contact Elucidate Bio to explore innovative spatial pipelines tailored to your program needs.
Psomagen
Network & Programme Sponsor
Psomagen, Inc., formerly Macrogen U.S.A., is a North American integrative omics solutions and contract laboratory services provider. The company makes cutting-edge technology and data analysis accessible to the academic, pharma, biotech and clinical markets. With both CLIA-certified and CAP-accredited facilities, its team delivers the highest-quality multiomics data using best-in-class DNA, RNA, and protein analysis systems. In conjunction with its bioinformatics capabilities, Psomagen offers a path to insights that is both simple and affordable. Learn more at psomagen.com.
Scailyte
Network & Programme Sponsor
Scailyte is an ETH Zürich spin-off with a best-in-class artificial intelligence platform for the discovery of complex molecular and cellular patterns from single-cell data. Our solution provides unprecedented insight into the disease and patients’ biology and enables the discovery of new clinically-relevant biomarker signatures by uncovering human’s hidden “single-cell” secrets.
Scailyte’s proprietary best-in-class data analysis platform ScaiVision™ associates multimodal single-cell datasets (scRNA-seq, CITE-seq, CyTOF, TCR-/BCR-seq, etc.) with clinical endpoints, such as disease progression, severity, treatment response and toxicity response to identify ultra-sensitive biomarker signatures and cell functionality states. Our discoveries elucidate drug MoA and inform on the risk benefit ratio.
The performance and clinically-relevant applications of Scailyte’s platform ScaiVision have been demonstrated in various clinical projects in immunology and oncology.
.png?length=600&name=ccf7bc56-af8b-49fe-b50e-b8bdf467ba91-2-5668375logo-StellaromicsLogo-(7).png)
Stellaromics
Network & Programme Sponsor
Stellaromics is dedicated to pioneering breakthroughs in 3D spatial multi-omics. The company's mission is to empower researchers with cutting-edge tools that illuminate the complexities of biological systems, enabling groundbreaking discoveries that improve human health.
The Stellaromics Pyxa platform enables researchers to visualize and analyze the spatial organization of cells and molecules within thick tissue samples at an unprecedented resolution. These breakthroughs, based on the company's STARmap and RIBOmap technologies, greatly expand upon applications of traditional 2D methods by offering a true 3D perspective, providing researchers with a deeper understanding of tissue organization, cellular interactions, and disease mechanisms.
Via Scientific
Network & Programme Sponsor
Via Scientific: AI-Powered Acceleration for Multi-Omics & Spatial Biology
AI-Driven Bioinformatics Innovation: Via Foundry, Via Scientific’s AI-powered platform, accelerates multi-omics research by eliminating bioinformatics bottlenecks. It enables research teams to build custom analysis pipelines without coding, automating data processing so scientists can focus on discovery. Foundry acts as a “force multiplier” for biomedical research, dramatically reducing time to insights.
Unified Multi-Omics & Spatial Insights: Designed for multi-omics and spatial biology, Via Foundry integrates genomics, transcriptomics, proteomics, and spatial data into a single platform. This fusion reveals deep biological insights missed by siloed analyses. With advanced visualization tools, Foundry handles large, complex datasets—accelerating discovery and development.
Empowering Next-Gen Research Collaboration: Built by scientists for scientists, Via Foundry upholds rigorous standards while enabling seamless collaboration across teams and long-term studies. With flexible deployment in the cloud or on-premises, it is trusted across academia, biotech, pharma, and healthcare. Combining AI-driven technology with an intuitive design, Via Scientific empowers researchers to unlock insights faster, more reliably, and at scale.
Visiopharm
Network & Programme Sponsor
Visiopharm® is a leading provider of AI-driven precision pathology software for research and diagnostics. In research, it is a technology leader providing tools that help scientists, pathologists, and image analysis experts produce accurate data for all types of tissue-based research. In diagnostics, it is a leader within clinical applications, with no less than eight diagnostic algorithms cleared under IVDR for EU and UK customers. These applications provide diagnostic decision support and can be easily activated and integrated into existing lab workflows.
Founded in 2002, Visiopharm is privately owned and operates internationally with over 750 customer accounts in more than 40 countries. The company's headquarters are located in Denmark's Medicon Valley, with legal entities in Sweden, the UK, Germany, the Netherlands, and the United States, and local representation in France and China.
Washington University
Network & Programme Sponsor
The McDonnell Genome Institute integrates cutting-edge ‘omics technologies and over 30 years of expertise to support your needs as your trusted partner. Explore our comprehensive solutions, including NGS, gene editing, stem cell biology, proteomics, and high-content imaging — custom-tailored to advance your research.
Start-Ups
Sponsors of Last Year's Discovery & Development US 2025
Platinum Sponsors
XtalPi
Platinum Sponsor
XtalPi is an innovative technology platform company powered by artificial intelligence (Al) and robotics. Founded in 2015 on the MIT campus, XtalPi is dedicated to driving intelligent and digital transformation in the Life Sciences and new materials industries. With tightly interwoven quantum physics, Al, cloud computing, and large-scale clusters of robotic workstations, XtalPi offers a range of technology solutions, services, and products to accelerate and empower innovation for biopharmaceutical and new materials companies worldwide.
Gold Sponsors
Almac
Gold Sponsor
Operating from state-of-the-art facilities in the UK, US and Europe, Almac Pharma Services is a fully regulatory approved CDMO partnering with global pharmaceutical and biotechnology industries.
With over 55 years' experience, we provide a comprehensive range of tailored solutions and access to a wealth of technical experts to support the delivery of your complex projects.
Almac’s integrated pharmaceutical development solutions are tailored to meet your needs. Our scientists can develop your clinical candidate into an optimum formulation and manufacture oral dose products for all stages of clinical trials.
We specialise in the manufacture & primary packaging of oral dosage forms as well as customised secondary packaging for all drug products including ultra-low temperature drug products.
Almac works in close partnership with our clients offering unique solutions designed to support the efficient and successful development, and commercialisation of new treatment options.
Chemaxon LLC
Gold Sponsor
Chemaxon is a leading cheminformatics company providing software solutions for property calculation and molecule design, chemical drawing, chemical search and compound data management. Certara acquired Chemaxon in 2024 to close gaps in the design-make-test-analyze cycle, bring promising leads into biosimulation, and speed up the launch of new medicines. Together we help you innovate with confidence by turning your discovery process into a competitive advantage.
• Chemaxon’s universal chemical drawing tool serves the needs of research scientists and gives them access to our industry-standard chemical intelligence.
• Our solutions support the creation of new molecule design ideas and enable medicinal chemists to utilize advanced computational techniques and visualize their data.
• We support the standardization of chemical information to improve the quality of training data for AI models and scale your search to the range of hundreds of millions – billions of chemical structures.
NOF CORPORATION
Gold Sponsor
NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators.
Optibrium
Gold Sponsor
Optibrium develops exceptional software and AI solutions that help scientists advance their discovery projects. Cutting-edge science, backed up by rigorous research, underpins their intuitive software for compound design, optimisation and data analysis. Optibrium’s comprehensive in silico platform improves the speed, efficiency, and productivity of the chemistry discovery process and supports a worldwide customer base, including leading pharma, biotech, agrochemical and flavouring companies and not-for-profit and academic groups. Optibrium was founded in 2009 and is headquartered in Cambridge, UK, with a US subsidiary, Optibrium Inc., based in Cambridge MA.
Sartorius BIA Separations
Gold Sponsor
Sartorius BIA Separations develops and manufactures market-leading CIM® monolithic chromatographic columns for the purification and analysis of large biomolecules, such as viruses, plasmids, and mRNA, which are applied in cell and gene therapies. The company’s Cornerstone® Biomanufacturing Development Services are the result of more than 25 years of hands-on experience with the most challenging biopharmaceutical products and offer a comprehensive approach of integrated process development solutions and novel technology designed to improve the robustness and yield of large biomolecules production while improving the safety of therapeutic products. Sartorius BIA's technology for manufacturing-scale purification is already used in the production of the first commercialized advanced therapeutics;the company also has a keen presence with novel drug candidates in the clinical pipeline.
Serán Bioscience, LLC
Gold Sponsor
Serán Bioscience is a leading CDMO that specializes in a variety of drug delivery and formulation approaches suited to optimizing bioavailability. Serán’s experienced teams will work with you to identify an appropriate formulation strategy to meet your program’s unique needs.
Serán’s team comprehensively assess technology options that consider bio-performance, stability, manufacturability, and drug product design. We are able to develop scalable formulations using efficient and material-sparing approaches and deliver you the simplest approach that meets your program’s needs.
Serán provides capsules, tablets, multi-particulates, and powder-in-bottle formulations.
Silver Sponsors
Brooks Automation
Silver Sponsor
Brooks Automation is the supplier of choice for robotics in laboratory automation. Brooks PreciseFlex Robots are ideally suited for drug discovery and development and clinical diagnostics applications, enabling labs to accelerate innovation and maximize productivity, while saving valuable lab space.
PreciseFlex Robots are used in a wide range of sample handling solutions. With advanced features to minimize deployment and teaching time and APIs for seamless integration into lab workflows, PreciseFlex Robots deliver scalable automation that is fast to deploy, energy efficient and delivers the highest workspace density and exceptional ROI.
.jpg?length=600&name=61ac7f24-46f1-4373-9564-8293c215c0a7-2-5668375logo-CDDV_L_BLUE_ON_WHITE_CMYK-(9).jpg)
Collaborative Drug Discovery, Inc. (CDD)
Silver Sponsor
Collaborative Drug Discovery (CDD) provides an intuitive software suite extensively used by creative biologists and chemists working in academic, biotechnology and pharmaceutical settings. Their flagship product, CDD Vault, enables researchers to intuitively organize and analyze both biological and chemical data, and to collaborate with partners through a straightforward web interface. CDD Vault helps scientists register entities, track inventory, manage bioassay data, capture experiments, calculate Structure-Activity Relationships (SAR), and mine their data for drug candidates. It also functions as an Electronic Laboratory Notebook (ELN) to capture and share experimental results. CDD Vault is differentiated through its intuitive design, superior performance, and workflows for secure, collaborative data sharing capabilities. CDD was founded in 2004 and presently serves thousands of researchers doing drug discovery all around the world. Learn more at www.collaborativedrug.com
Concept Life Sciences
Silver Sponsor
Concept Life Sciences is a UK-based drug discovery CRO, helping global pharma and biotech companies accelerate their drug candidate to clinic by offering integrated drug discovery programs as well as high quality solutions in Biology, Chemistry, ADME/ DMPK, Toxicology and GMP manufacturing. Concept Life Sciences has helped pharma and biotech companies accelerate 30 candidates to preclinical stage, 21 candidates to clinic, and 4 candidates to market.
FRONTEO
Silver Sponsor
About FRONTEO URL: https://www.fronteo.com/
FRONTEO supports experts across diverse technological fields by delivering insights that spark innovation through its proprietary AI engine, KIBIT. KIBIT employs a unique natural language processing technology (patented in Japan and the United States) that enables high-speed, high-precision text analysis without the large volumes of training data and computing power required by Large Language Models (LLMs). Using patented visualization technology to map relationships within analyzed information, KIBIT uncovers insights that might otherwise remain hidden. In recent years, this technology has also been applied to hypothesis generation and target discovery in drug development.
Guided by its mission to enhance fairness in the information society by uncovering opportunities and risks hidden in records, FRONTEO applies KIBIT’s unique capabilities in life sciences AI, risk management (including compliance, economic security, and legal tech AI), and digital transformation support.
Founded in August 2003, FRONTEO was listed on the Tokyo Stock Exchange Mothers Market (now the Growth Market) on June 26, 2007. The company has offices in Japan, the United States, South Korea, and Taiwan, and holds a Type 1 Marketing License for Medical Devices as well as registration for the sale of controlled medical devices. As of March 31, 2025, FRONTEO’s capital stands at 899,176,000 yen.
HUB Organoids
Silver Sponsor
HUB Organoids is a pioneering biotechnology company specializing in the application of Organoid Technology to drug discovery, personalized medicine, and disease modeling. Founded in 2013 following the discovery of adult stem cells, HUB´s drug development platform uses advanced 3D organoid models derived from patient tissues, enabling more accurate and predictive research for preclinical testing and therapeutic development. HUB´s innovative platform accelerates the discovery of effective treatments by closely mimicking human biology and is available on a fee for service basis to scientists working in drug discovery and development in the therapeutic areas of oncology, inflammation/IBD, infectious diseases, and for toxicology investigation. HUB is now part of the Life Science Business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the US and Canada.
MilliporeSigma
Silver Sponsor
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, unites our Millipore® and SAFC® products and services into a comprehensive portfolio that gives you the options needed to confidently solve your most urgent bio/pharmaceutical challenges.
We support every step of your product development and manufacturing from upstream and downstream to formulation with a broad portfolio that includes single-use assemblies and systems, chromatography and filtration technologies, process analytical technology, high-quality raw materials and excipients complemented by a tailored service offering.
Our options become your opportunities, empowering you to design a roadmap for efficient and scalable bio/pharmaceutical processes.
Bronze Sponsors
Ardena
Bronze Sponsor
Ardena is a specialist CDMO and bioanalytical CRO enabling precision medicines through fully integrated solutions across the drug development lifecycle. As a mid-sized, agile organization, we combine deep scientific expertise with a flexible, customer-focused approach, supporting biotech and pharmaceutical companies in bringing innovative therapies to patients faster.
Our capabilities span drug substance and drug product development, with expertise in nanomedicine, solid-state chemistry, bioanalytical services, and comprehensive CMC regulatory support. With state-of-the-art facilities across Europe and the US, we are equipped to manage complex molecules and customized development programs at any stage, from preclinical studies to clinical manufacturing and beyond.
At Ardena, we pride ourselves on providing technically robust solutions tailored to each client’s needs. Our scientists work closely with partners, applying extensive know-how to overcome development challenges and deliver high-quality results efficiently. By integrating services under one roof, we simplify project management and accelerate timelines, enabling innovators to focus on science while we handle the complexity.
Through our expertise and collaborative approach, we help our partners turn scientific innovation into successful therapies.
ATS Scientific Products
Bronze Sponsor
We specialize in delivering comprehensive lyophilization and evaporation technologies that support the full product development journey—from early-stage research to large-scale commercial manufacturing. With decades of expertise, a global installed base, and a deep commitment to customer success, we empower pharmaceutical, biotechnology, and diagnostics companies to scale with confidence.
Our trusted lyophilization solutions are complemented by Genevac’s cutting-edge evaporation systems, including the versatile EZ-2 Series for high-performance, seamless evaporation and the HT Series 3i for high-throughput applications that save time and space. Featuring Dri-Pure® anti-bumping technology for foam-free, contamination-free results, intuitive touchscreen controls, and advanced crystallization capabilities, Genevac simplifies your workflow while maximizing efficiency.
Whether you're working in medicinal chemistry, oligo synthesis, or beyond, we provide the performance, reliability, and partnership you need to bring your products from concept to commercialization—effortlessly.
BioDuro-Sundia
Bronze Sponsor
BioDuro, an Advent International portfolio company is a trusted, leading contract research development, and manufacturing organization (CRDMO) for 29 years. We provide our biotech and pharmaceutical partners with fully integrated services to support their efforts from target identification through to commercial drug product manufacturing. The company is based in the US with operations in China, totaling 2,000+ scientists and 7 global sites across 6 cities.
Core expertise includes small and large molecule discovery, development and scale-up, support for IND submission, and unique technology platforms such as bioavailability enhancement of insoluble compounds. The one-stop-shop operation helps biotech and pharma partners across the globe to significantly accelerate discovery and de-risk development to create higher value outcomes. We adhere to one global highest standard of compliance and business operation code. Science-driven, customer-oriented, flexible, people-focused culture enables us to provide top-tier integrated, fast and flexible tailored services to our customers to meet their unique needs and accelerate our development timeline.
For more information about BioDuro, please visit our website at www.bioduro-sundia.com
eMolecules
Bronze Sponsor
eMolecules is a leading provider of chemical compound search-and-fulfillment services for early drug discovery research. Founded in 2005, the company's mission is to accelerate drug discovery timelines by improving efficiencies in compound search and acquisition processes. eMolecules offers a powerful digital platform that connects chemists to the world's largest readily-available chemical space, with over 83 million specialty chemistry and biology part numbers. In recent years, eMolecules has significantly expanded its capabilities through strategic acquisitions. The company acquired Frontier Scientific Inc. and Frontier Agricultural Sciences in 2022, Specs Compound Handling B.V. in 2023, and Synple Chem AG in 2024. These acquisitions have strengthened eMolecules' position as a global one-stop-shop solution provider for efficient chemical compound procurement, full-service compound management, and automation solutions. With offices across North America and Europe, the eMolecules team serves the top 15 pharmaceutical companies worldwide and many more pharma, biotech, and academic clients.
Lubrizol
Bronze Sponsor
The Lubrizol Corporation, a Berkshire Hathaway company, delivers specialty chemistry with global reach and local presence.
Lubrizol is a leading provider of multifunctional ingredients and excipients for the pharmaceutical industry. Specifically, Carbopol®, Polycarbophil and Pemulen polymer excipients for pharmaceutical formulations. We focus on several applications including extended/modified release, mucoadhesion, topical, and ophthalmic applications. We also offer solubility-enhancing polymers for class BCS II or IV highly-insoluble APIs, our novel excipients: Apinovex™ polymers for oral solid dosage ASDs and Apisolex™ for injectable applications.
For over six decades, the pharmaceutical industry has utilized multifunctional Carbopol® polymers for developing differentiated drug product innovations. Today, the Carbopol® polymers range continues to provide highly effective controlled-release properties for oral tablets at low usage levels, critical rheological and bioadhesive properties for topical formulations, and patient-centric benefits across multiple dosage forms, among many other advantageous properties.
We also offer established FDA IID ingredients in a variety of applications.
nanoComposix (A Foris Life Sciences Company)
Bronze Sponsor
nanoComposix (A Fortis Life Sciences Company) headquartered in San Diego, CA, USA., has specialized in the design, development, and scaled manufacturing of nanomaterials for therapeutic, diagnostic, energy, and optical applications for over 20 years. From feasibility to clinical or commercial production, we partner with companies and researchers to translate nanoparticle-enabled technologies into viable products. nanoComposix is an ISO 13485:2016 Certified, FDA-registered developer and contract manufacturer.
Unchained Labs
Bronze Sponsor
Here’s the deal. We’re all about helping biologics and gene therapy researchers break free from tools that just don’t cut it. Unleashing problem-tackling solutions that make a huge difference in the real science they do every day. That’s our mantra, our promise and we own it.
Network & Programme Sponsors
Adare Pharma Solutions
Network & Programme Sponsor
Adare Pharma Solutions is a global technology-driven CDMO providing end-to-end integrated services, from product development through commercial manufacturing and packaging, with small molecule expertise focusing on oral dosage forms. Our specialized technology platforms provide taste masking, customized release, solubility enhancement, and patient-centric dosing solutions. With a proven history in drug delivery, Adare has developed and manufactured more than 65 products sold by customers worldwide. Adare operates facilities in the US and Europe, with nearly 800 global employees. We have the expertise and proven track record to guide projects from clinical research stages through optimization, validation, and approval.
Ascendia Pharmaceutical Solutions
Network & Programme Sponsor
Ascendia Pharmaceutical Solutions is a US-based specialty CDMO that provides custom formulation development, analytical support, and cGMP manufacturing for both small molecule and biologic drug products. Our experts deliver sophisticated formulations to enhance bioavailability, solubility and stability, while reducing toxicity using GRAS (Generally Recognized As Safe) materials and four proprietary nanotechnology platforms – NanoSol® (solid nanoparticle), EmulSol® (nano-emulsion), AmorSol® (amorphous solid dispersion) and LipidSol®(liposome and LNP) – along with oral controlled release and long-acting injectable (LAI) solutions. Ascendia offers its aseptic and non-aseptic manufacturing services to biotech and pharmaceutical companies who seek a CDMO partner that is steeped in Socratic process for their formulations. As candidates advance from preclinical and early clinical development to late-stage clinical trials and beyond, Ascendia provides efficient scale-up for oral, injectable and transmucosal/ophthalmic programs. For more information, visit AscendiaCDMO.com.
Biognosys
Network & Programme Sponsor
At Biognosys, we believe that deep proteome insights hold the key to breakthrough discoveries that transform science for better lives. With our versatile portfolio of next-generation proteomics solutions, including the TrueDiscovery, TrueTarget, and TrueSignature research service platforms, our flagship software Spectronaut®, and the PQ500 kit, we make the proteome actionable to empower research, drug development, and clinical decision-making. Our solutions provide a multi-dimensional view of protein expression, function, and structure in all biological species and sample types.
Our unique, patented technologies utilize high-resolution mass spectrometry to quantify thousands of proteins with industry-leading precision, depth, and throughput. Through our strategic partnership with Bruker (Nasdaq: BRKR), we make proteomics globally accessible.
BrainXell
Network & Programme Sponsor
BrainXell provides high-purity, iPSC-derived human neurons and glia for research and development. Utilizing proprietary technology, we generate high-purity, subtype-specific neurons that mature rapidly and are ready for a variety of assays. Multiple neuron subtypes are available from control lines and can be made in custom batches from 50 million to 10 billion neurons from unique iPSC lines.
Our custom services include the culture, expansion, and differentiation of patient-derived iPSCs into mature neural and glial cells, which are then cryopreserved and shipped to your laboratory ready for experimentation. This process can be applied to human iPSCs and ESCs sourced from biobanks, healthy individuals, or patients with CNS diseases. Beyond differentiation, we can also reprogram fibroblasts into iPSCs and provide low throughput a la carte assay services.
Whether you require multiple lines produced in small batches or a billion neurons from a single cell line, we understand that aims and goals can differ. That’s why we provide tailored services to adjust cell line numbers and batch quantities according to your individual needs. Additionally, we offer storage for your specific cell lines, enabling quick production of extra or recurring batches as necessary.
Upon receipt of your iPSC cells, we can typically deliver up to half a billion differentiated neurons in four to six months
DP-BIO
Network & Programme Sponsor
DPBIO is a pioneering innovator based in California, specializing in high-throughput droplet microfluidic technology and providing cutting-edge life science solutions to researchers and industry leaders worldwide.
At DPBIO, we integrate advanced microfluidic technology with life sciences to develop comprehensive solutions, including microfluidic chips, instruments, and reagents. Our flagship products—such as the CytoSpark® High-throughput Screening System, OMNIdrop System—empower scientists in antibody discovery, enzyme evolution, strain screening, small-molecule drug screening, cancer research, early disease detection, viral quantification, and biopharmaceutical quality control.
Trusted by leading biotech and pharmaceutical companies, top-tier research institutions, and clinical laboratories worldwide, DPBIO is committed to advancing life sciences with high-performance analytical and detection systems. Our mission is to accelerate drug discovery, synthetic biology, biomedical research, and precision medicine, driving breakthroughs that transform life science innovation.
Drugbank
Network & Programme Sponsor
In biopharma, the advantage belongs to those who see the shift before it happens. DrugBank’s clinical development intelligence platform gives strategy, R&D, and BD teams the insight to stay ahead by unifying clinical, target, mechanism, and disease data into a single source of truth that connects competitive moves with scientific and market context. It is tuned to your focus and delivers cross-domain insights in minutes, helping you spot threats, validate opportunities, and build defensible, board-ready narratives for faster, more confident decisions.
NextPharma
Network & Programme Sponsor
NextPharma are a leading CDMO with 10 manufacturing sites and 2,500 employees. We work from pre-clinical support through to commercial supply at each of our sites, covering a wide variety of oral, topical, ophthalmic and suppository based dosage formats.
NextPharma have industry-leading expertise in solubility and bioavailability enhancement of BCS Class II & IV APIs, utilising lipid-based formulations and Hot Melt Extrusion (HME) technologies to optimise drug delivery and performance.
We also offer in-house analytical services, primary/secondary packaging and additional clinical trial services, alongside regulatory support and global logistics.
Nomic Bio
Network & Programme Sponsor
Nomic was founded to make biology easier to measure and enable scientists to extend lives by making proteomics accessible, scalable, and routine. Powered by its proprietary nELISA® technology, Nomic delivers large-scale, quantitative, and cost-effective protein data to accelerate discovery, development, and translation. Its end-to-end service combines flexible content, expert support, and analysis-ready outputs—enabling seamless integration of proteomics across all stages of drug and biomarker development. Nomic’s mission is to make proteomics ubiquitous for modern biology.
Onyx Scientific Limited
Network & Programme Sponsor
Onyx Scientific, the CDMO division of IPCA Laboratories, has specialized in small molecule drug substance development and manufacturing for 25 years. From our MHRA-licensed facilities in the UK, we provide seamless support for early development for candidate APIs, clinical phase production, and commercial supply.
Our dedicated solid-state and analytical chemistry teams accelerate development timelines, offering both integrated services and full-service outsourced solutions to complement your in-house efforts. With extensive expertise in early-stage development, we adopt a pragmatic, fit-for-purpose approach that prioritizes rapid process development while paving the way for future GMP campaigns.
For projects requiring scale-up beyond Phase II, we ensure continuity through seamless transitions within our global network, leveraging sister sites and expert teams in the USA and India to meet your long-term manufacturing needs.
Phosphorex
Network & Programme Sponsor
Phosphorex is a leading provider of drug delivery technologies and solutions. By harnessing the potential of microspheres and nanoparticles for drug delivery, Phosphorex offers tailored solutions and enabling technologies to optimize a drug's release rate, targeting ability, bioavailability, and deliverability, with the goal of achieving desired therapeutic effects while reducing adverse clinical outcomes. Phosphorex supports pharmaceutical and biotech companies through all phases of their development, from proof of concept to clinical studies and will be offering cGMP manufacturing services soon. Phosphorex's mission is to help our partners solve complex problems and develop successful drugs to help patients. Additional information about Phosphorex is available at www.phosphorex.com or follow us on LinkedIn.
Sanyou Biopharmaceuticals Co., Ltd
Network & Programme Sponsor
Sanyou Biopharmaceuticals is a global leader in antibody discovery, engineering, and development, advancing biologics innovation from target discovery through manufacturing. With our super-trillion antibody library and AI-driven, wet-lab–integrated platforms, we offer comprehensive solutions including antibody discovery and engineering, protein and antigen production, gene and vector engineering, and cell line development. By combining cutting-edge technologies with an integrated product pipeline, Sanyou Bio delivers high-quality antibodies, custom services, and end-to-end support to accelerate drug discovery with speed, reliability, and innovation.
Symeres
Network & Programme Sponsor
As your transatlantic drug discovery and development partner, we combine proven expertise, adaptive thinking, and attentive collaboration to get you where you need to be.
Our multidisciplinary teams are deeply experienced in small molecules, from discovery to Phase II, and bring specialized capabilities in biopharmaceuticals and drug delivery. Through scientific rigor and forward-thinking strategies, we proactively identify challenges, reduce risk, and realize the full value of your program.
Operating across Europe and North America, we collaborate seamlessly — giving you the clarity, quality, and confidence to move forward decisively.
Thinking ahead. Delivering above.
Trait Biosciences
Network & Programme Sponsor
Trait Biosciences is a research-focused company developing science-based solutions that make cannabinoids soluble in water. Trait’s technologies are unique, IP-protected, and enable superior cannabinoid performance. Our free-flowing API powders are manufactured under pharma-grade quality standards and deliver competitive bioavailability, stability, and efficacy. The high purity of our APIs solves for many formulation challenges and allows easy incorporation across all routes of administration. Our APIs empower health and wellness providers—from pharma to food and beverage—to accelerate development timelines and bring differentiated, high-quality cannabinoid-based solutions to market.
Looking ahead, Trait’s research will continue to advance water-soluble cannabinoid technologies and expand into new application areas.
Start-Ups
Navega Therapeutics
Start Up Zone
Navega Therapeutics is a preclinical stage company developing epigenetic gene therapies focused on neurological and inflammatory diseases.
Some company highlights:
- Leading AI-enabled zinc-finger tools to modulate the epigenome for therapeutic benefit (platform technology).
- The company’s lead program, NT-Z001, an epigenetic therapy targeting Nav1.7, has shown proof-of-concept across five different models of pain, has completed safety studies in mice and a pilot study in NHP, and is completing IND-enabling studies.
- Lead candidates selected for 1) Nav1.8 and 2) a dual candidate targeting simultaneously Nav1.7 + Nav1.8.
- Novel target discovered (patent filed) for rheumatoid arthritis, demonstrating disease modification and pain relief.
- With a strong IP portfolio internally developed and in-licensed from UCSD, we are well poised to create the medicines of the future.
OCMS Bio
Start Up Zone
OCMS Bio has developed a rapid “function-first” antibody discovery and engineering platform that creates novel best-in-class antibodies. Fully integrated with the AI design cycle, the OCMS platform uses synthetic or rationally designed antibody libraries and delivers ranked functional data for every tested candidate. This approach enables rapid, reliable progress from computer models to in vitro validation, to algorithm refinement, and in vivo efficacy. As a proof of concept, OB2401 RSV lead molecule demonstrated functional superiority in vitro and recently achieved POC in vivo. The OB2402 Activin RII inhibitor program has entered in vivo testing and is close to POC nomination. The OCMS platform streamlines the identification of top biological candidates, improves AI design with direct biological validation, and removes discovery bottlenecks.Fully integrated with the AI design cycle, OCMS starts with in silico sequences and delivers ranked functional data for all tested candidates in the AI/ML-compartible format. This approach ensures rapid, reliable progression from computer models to in vitro and in vivo validation. As a proof-of-concept, OB2401 RSV lead molecule was selected due to its functional superiority to existing therapeutics, and outperformed Nirsevimab in the gold-standard cotton rat animal model. OB2402 Activin RII inhibitor program has now entered in vivo testing and nears the POC nomination. OCMS platform streamlines identification of superior biologic candidates, enhances AI design with direct biological validation, and eliminates discovery bottlenecks.
Redwood AI
Start Up Zone
Born out of Stanford University and University of British Columbia, Redwood AI is a technology company dedicated to transforming pharmaceutical drug development through artificial intelligence. The company brings together a multidisciplinary team of data scientists, chemists, and seasoned biopharmaceutical executives with the shared mission of accelerating the manufacturing of new therapeutic drugs.
Redwood AI’s core platform is an AI-driven software solution capable of generating multiple viable synthetic routes for a given compound within seconds. This rapid analysis allows chemists to evaluate alternative pathways side by side, considering efficiency, cost, yield, and purity. Beyond proposing routes, the system predicts key chemical properties such as stability, catalyst requirements, and potential degradation pathways, helping researchers avoid costly trial-and-error experimentation. It also maps the global availability of precursor compounds, identifies suppliers, compares pricing, and highlights chemical hazards and safety risks associated with each option. By combining AI-enabled route generation, predictive modeling, and real-world supplier data, the platform provides an end-to-end synthesis planning tool that accelerates decision-making and improves outcomes. Upon commercialization, it will be delivered as a subscription-based SaaS product, giving biopharmaceutical teams direct access to a powerful, high-speed synthesis design system.
Saguaro Technologies
Start Up Zone
o Saguaro develops non-toxic fluorescent dyes that offer new insights into biological systems, empowering researchers to advance their understanding of disease and improve decision-making in drug development.
o Saguaro’s non-toxic dyes set a new standard. They are:
Biologically inert. Allowing studies in the most physiologically relevant conditions and cell models.
Wash-free. Ideal for high-throughput screening assays.
Ideal for deep and uniform staining of 3D cell cultures.
o Dyes Portfolio
ChromaLIVE dye. The image-profiling approach with the richest density of cellular data, allowing scientists to access a new dimension of insights on drug candidates.
NucleoLIVE dye. Non-toxic nuclear dye for real-time cell count and viability data.
MortaLIVE dye. Fast and easy cytotoxicity studies, providing real-time insights.
o Compound Screening and Profiling Service
Drug Profiling. Spare your resources and let the leading experts in live-cell screening take care of your assays with a state-of-the art screening platform. Using our reference dataset of well-annotated compounds, we profile your drug candidates using ChromaLIVE, the leading technology for profiling drugs with images.
Customer Pilot Tests. Initial evaluation of new reagents within a drug discovery group requires extra resources. We facilitate this process by running the pilot tests for our customers.
SiCare
Start Up Zone
SiCare Bio is enabling the next generation of nano-therapeutics through its precision nanoporous silicon dioxide particles. SiCare’s drug delivery platform is utilized by pharmaceutical partners to develop innovative long-acting and intracellular delivery solutions. Underpinning SiCare’s platform is its unique form of high-precision, biocompatible nanoporous silica.
